학술논문
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
Document Type
Article
Author
Source
In The Journal of Allergy and Clinical Immunology April 2016 137(4):1103-1110
Subject
Language
ISSN
0091-6749